Your browser doesn't support javascript.
loading
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey.
Orsi, G; Di Marco, M; Cavaliere, A; Niger, M; Bozzarelli, S; Giordano, G; Noventa, S; Rapposelli, I G; Garajova, I; Tortora, G; Rodriquenz, M G; Bittoni, A; Penzo, E; De Lorenzo, S; Peretti, U; Paratore, C; Bernardini, I; Mosconi, S; Spallanzani, A; Macchini, M; Tamburini, E; Bencardino, K; Giommoni, E; Scartozzi, M; Forti, L; Valente, M M; Militello, A M; Cascinu, S; Milella, M; Reni, M.
Afiliación
  • Orsi G; Medical Oncology Department, IRCCS San Raffaele Scientific Institute, Milan, Italy; Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Di Marco M; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola - Malpighi University Hospital, Bologna, Italy.
  • Cavaliere A; Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy.
  • Niger M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Bozzarelli S; Department of Medical Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center - IRCCS, Rozzano (Milan), Italy.
  • Giordano G; Unit of Medical Oncology and Biomolecular Therapy, Policlinico Riuniti, Foggia, Italy; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
  • Noventa S; Department of Medical Oncology, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
  • Rapposelli IG; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST, Meldola, Italy.
  • Garajova I; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Tortora G; Unit of Medical Oncology, Comprehensive Cancer Center, Fondazione Policlinico Universitario, Agostino Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.
  • Rodriquenz MG; Oncology Unit, Ospedale IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy.
  • Bittoni A; Oncology Unit, Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I, GM Lancisi, G Salesi di Ancona, Ancona, Italy.
  • Penzo E; Medical Oncology Department, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
  • De Lorenzo S; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Peretti U; Medical Oncology Department, IRCCS San Raffaele Scientific Institute, Milan, Italy; Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Paratore C; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin, Italy.
  • Bernardini I; Medical Oncology Unit, Ospedale Ramazzini, Carpi (MO), Italy.
  • Mosconi S; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Spallanzani A; Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Macchini M; Medical Oncology Department, IRCCS San Raffaele Scientific Institute, Milan, Italy; Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Tamburini E; Medical Oncology and Palliative Care Department, Azienda Ospedaliera Cardinale G. Panico, Tricase-Lecce, Italy.
  • Bencardino K; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Giommoni E; Medical Oncology Division, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy.
  • Scartozzi M; Medical Oncology, University and University Hospital, Cagliari, Italy.
  • Forti L; Medical Oncology Division, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.
  • Valente MM; Medical Oncology Department, IRCCS San Raffaele Scientific Institute, Milan, Italy; Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Militello AM; Medical Oncology Department, IRCCS San Raffaele Scientific Institute, Milan, Italy; Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Cascinu S; Medical Oncology Department, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
  • Milella M; Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy.
  • Reni M; Medical Oncology Department, IRCCS San Raffaele Scientific Institute, Milan, Italy; Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: reni.michele@hsr.it.
ESMO Open ; 6(5): 100238, 2021 10.
Article en En | MEDLINE | ID: mdl-34392104
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: ESMO Open Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: ESMO Open Año: 2021 Tipo del documento: Article País de afiliación: Italia